Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

HALO May 11, 2026

Halozyme Q1 2026 Earnings Call - ENHANZE Royalties Surge 43%, $1B Buyback, Hypercon Pipeline Accelerates

Halozyme delivered a powerful first quarter, with revenue jumping 42% year-over-year to $377 million and non-GAAP EPS rising 44% to $1.60. The growth was driven by a 43% surge in ENHANZE royalties to ...

  • Revenue surged 42% year-over-year to $377 million in Q1 2026, driven by a 43% increase in ENHANZE royalties to $241 million.
  • Non-GAAP EPS rose 44% to $1.60, and adjusted EBITDA grew 42% to $230 million, reflecting strong operating leverage.
  • Management reaffirmed 2026-2028 guidance, projecting ENHANZE royalties to exceed $1 billion in 2026, representing 30-35% growth over 2025.
  • +7 more takeaways
SIBN May 11, 2026

SI-BONE Q1 2026 Earnings Call - Raised Guidance on Strong Revenue Growth and Profitability Expansion

SI-BONE delivered a strong first quarter with worldwide revenue of $52.6 million, up 11.2% year-over-year, driven by robust demand for its iFuse platform and early momentum from new product launches. ...

  • Worldwide revenue reached $52.6 million, up 11.2% year-over-year, with U.S. revenue at $49.3 million (+10%) and international revenue at $3.3 million (+34%).
  • Full-year 2026 revenue guidance raised to $230–$233 million, implying 14–16% year-over-year growth, with expectations for quarterly acceleration.
  • Gross margin held steady at 79.8%, with full-year guidance increased by 100 basis points to approximately 79%, driven by favorable procedure mix and operational efficiencies.
  • +12 more takeaways
ALTI May 11, 2026

AlTi Global Q1 2026 Earnings Call - Revenue Growth Masks Expense Overhang

AlTi Global delivered a quarter defined by stark contrasts: revenue surged 28% to $73 million, driven by a strong acquisition and resilient recurring fees, yet the firm is grappling with a bloated cos...

  • Total revenue rose 28% year-over-year to $73 million, fueled by strong growth in management fees and investment distributions.
  • Recurring management and advisory fees increased 16% to $52 million, highlighting the stability of the firm's core business model.
  • Assets under management grew 9% to $49 billion, driven by investment performance and the Kontora acquisition, despite market volatility.
  • +7 more takeaways
LENZ May 11, 2026

LENZ Therapeutics Q1 2026 Earnings Call - VIZZ Launch Acceleration Efforts Outpace Early Script Growth

LENZ Therapeutics is in the early, high-friction phase of building a new presbyopia category with VIZZ, generating $1.9 million in Q1 revenue and 25,000 filled prescriptions. The company acknowledges ...

  • Q1 net revenue reached $1.9 million, comprising $1.7 million in product sales and $250,000 in license revenue from international partnerships.
  • Approximately 25,000 paid and filled prescriptions were generated in Q1, marking a 19% sequential increase from Q4.
  • The company has onboarded over 10,000 unique prescribers in just two quarters, with VIZZ generating roughly 70% more scripts per prescriber than VUITY at a comparable stage.
  • +7 more takeaways
CBLL May 11, 2026

Ceribell Q1 2026 Earnings Call - Record Account Growth and New Market Entries Signal Acceleration

Ceribell delivered a strong first quarter with revenue of $26.5 million, up 29% year-over-year, driven by record headband utilization and its largest quarter of net new account additions. The company ...

  • Revenue of $26.5 million grew 29% year-over-year and 7% sequentially, driven by record headband utilization and record net new account additions.
  • Ceribell added 33 net new hospital accounts in Q1, marking its strongest single quarter of account growth since becoming a public company.
  • The company initiated the full commercial launch of its neonate and pediatric seizure monitoring products following successful 5-site pilots.
  • +7 more takeaways
BW May 11, 2026

Babcock & Wilcox Q1 2026 Earnings Call - AI Data Centers and Coal Revival Drive Record Backlog Growth

Babcock & Wilcox delivered a quarter that defied the usual seasonal drag. Revenue jumped 44% year-over-year to $214 million while adjusted EBITDA nearly quadrupled to $16.1 million. The real story sit...

  • Revenue surged 44% year-over-year to $214 million, beating both company and street expectations.
  • Adjusted EBITDA jumped 296% to $16.1 million, driven by higher project volume and strong parts and services demand.
  • Bookings skyrocketed over 1,900% to $2.5 billion while backlog grew 483% to $2.7 billion, signaling a massive inflection point.
  • +7 more takeaways
MVST May 11, 2026

Microvast Q1 2026 Earnings Call - Revenue Halves as CAF Powertrain Push and Huzhou Ramp Face Tariff Headwinds

Microvast reported a sharp 48% year-over-year revenue decline in Q1 2026, driven by a pull-forward of U.S. deliveries into 2025 ahead of tariff uncertainty and slower OEM rollouts in Europe. Despite t...

  • Revenue fell 48% year-over-year to $60.6 million, driven by a 48% drop in volume from 536 MWh to 274 MWh as U.S. customers pulled deliveries into 2025 to avoid tariff uncertainty.
  • Gross margin held resilient at 31.6% despite lower volumes, offsetting raw material price increases and tariff-related cost inflation through disciplined cost management.
  • Management announced a new 290 amp-hour LFP battery pack and an integrated CAF electric powertrain for school buses, positioning it as a plug-and-play solution aiming for diesel cost parity under 10 years without subsidies.
  • +7 more takeaways
QUBT May 11, 2026

Quantum Computing Inc. Q1 2026 Earnings Call - Aggressive M&A Strategy Drives Revenue Surge Amid Heavy R&D Spend

Quantum Computing Inc. reported a massive revenue jump in Q1 2026, driven almost entirely by the acquisitions of Luminar Semiconductor and NuCrypt, rather than organic growth. Revenue surged to $3.7 m...

  • Revenue surged to $3.7 million in Q1 2026, up from $39,000 in the prior year quarter, driven almost entirely by the acquisitions of Luminar Semiconductor and NuCrypt. Excluding acquisitions, organic revenue was just $204,000.
  • Operating expenses nearly tripled to $19.8 million, primarily due to a substantial increase in headcount and approximately $6 million in one-time M&A transaction costs for the NuCrypt and Luminar deals.
  • The company maintains a fortress balance sheet with $1.4 billion in cash and investments, generating $13.5 million in interest income for the quarter, which more than offsets the $4.1 million net loss.
  • +7 more takeaways
SLI May 11, 2026

Standard Lithium Ltd Q1 2026 Earnings Call - Secures First Major Offtake Agreement and Advances Toward 2026 FID

Standard Lithium reported a Q1 2026 net loss of $2.7 million, driven by higher demonstration plant costs, though the company remains on track for a final investment decision at its Southwest Arkansas ...

  • Standard Lithium reported a Q1 2026 net loss of $2.7 million, up from $1.6 million in Q1 2025, primarily due to $0.4 million in higher demonstration plant costs, though general and administrative expenses decreased slightly by $0.1 million.
  • The company secured its first binding offtake agreement with Trafigura for 8,000 metric tons per year of battery-grade lithium carbonate over 10 years, representing over 40% of its targeted 80% offtake coverage for the Southwest Arkansas project.
  • Operational milestones at the Arkansas demonstration plant include processing over 1 million barrels of live Smackover brine over six years, achieving 95%+ lithium recovery and 99%+ contaminant rejection, with zero safety incidents across 340,000 man-hours.
  • +7 more takeaways
GPRO May 11, 2026

GoPro Q1 2026 Earnings Call - Strategic Sale Process Launch Amid Product Pivot and Margin Pressure

GoPro is formally exploring a sale or strategic merger following unsolicited inbound interest triggered by its expanded focus on defense and aerospace applications. CEO Nicholas Woodman confirmed full...

  • GoPro has launched a formal strategic review process to evaluate a sale or merger, triggered by unsolicited inbound inquiries after announcing its focus on defense and aerospace opportunities.
  • CEO Nicholas Woodman confirmed he fully supports the strategic process, stating there is unrealized value in GoPro’s technology, IP, brand, and manufacturing capabilities that a sale could unlock.
  • Q1 2026 revenue fell to $99 million from $134 million in the prior year period, reflecting macro pressures in consumer electronics including rising memory costs and supply chain constraints.
  • +12 more takeaways